Outset Medical to Present at RBC Global Healthcare Conference
Outset Medical (Nasdaq: OM) announced that its management will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 10:30 a.m. ET.
Rhea-AI Summary
Outset Medical (Nasdaq: OM) announced that its management will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 10:30 a.m. ET.
A live and archived webcast will be accessible via the Investors section of the Outset Medical website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – OM
On May 12, the first trading day after this news, OM closed 5.21% above the previous close.
Data tracked by StockTitan Argus for the May 12 session.
Key Figures
- Conference date
- May 19, 2026
- RBC Capital Markets Global Health Care session
- Presentation time
- 10:30 a.m. Eastern time
- Scheduled start of conference session
- Webcast availability
- Live and archived
- Session webcast on Outset Medical investors website
Historical Context
-
Announced Q1 2026 results date and conference call logistics.
-
Reported RSU inducement awards for two new hires under Nasdaq rules.
-
Named new EVP of Commercial to lead acute, post‑acute and home care teams.
-
Reported Q4/FY25 growth, margin expansion, FDA clearance and 2026 guidance.
-
Announced FDA 510(k) clearance for next‑generation Tablo hemodialysis system.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m. Eastern time.
The live and archived webcast of the session will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Contact
Investors@outsetmedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.